RiverVest Venture Fund III, L.P. → Reneo Pharmaceuticals, Inc. OKUR

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

163,904 shares short · +1958.6% vs prior

Other 13D/G Filings on Reneo Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-07	SCHEDULE 13D	AI Biotechnology LLC	19.99%	9,091,532	view →
2025-01-21	SCHEDULE	RiverVest Venture Fund III, L.P.	1.55%	196,198	view →
2024-10-08	SC	New Enterprise Associates 15, L.P.	—	—	view →
2022-01-27	SC	Novo Holdings A/S	—	—	view →

Other Filings by RiverVest Venture Fund III, L.P.

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	OnKure Therapeutics, Inc. OKUR	1.55%	196,198	view →
2025-01-10	SCHEDULE	SPRUCE BIOSCIENCES, INC. SPRB	4.20%	1,759,521	view →
2023-05-30	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2021-01-08	SC	Allakos Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →